![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0006.png)
Page 26
Note:
O c t o b e r 1 5 - 1 6 , 2 0 1 8 | T o k y o , J a p a n
Obesity Congress 2018, Diabetes Congress 2018 & Vaccines Congress 2018
Biomedical Research
|
ISSN: 0976-1683
|
Volume 29
2
nd
WORLD OBESITY CONGRESS
2
nd
WORLD VACCINES AND IMMUNOLOGY CONGRESS
&
&
DIABETES AND ENDOCRINOLOGY
International Conference on
Joint Event on
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
alliedacademies.comYEARS
Patricia Avila Fabrini, Biomed Res 2018, Volume 29 | DOI: 10.4066/biomedicalresearch-C5-013
VACCINATION AGAINST YELLOW FEVER IN
A PATIENT ON IMMUNOBIOLOGICAL WITH
DIAGNOSIS OF PSORIATIC ARTHRITIS
Patricia Avila Fabrini
Santhè Clinic, Brazil
P
atients with psoriatic arthritis and other immunomediated chronic dis-
eases present a risk of infection greater than the normal population. The
increased risk is due to the disease, as well as the drug therapy employed.
Vaccination is one way to prevent infectious diseases. It is effective in reduc-
ing morbidity and mortaslity in patients with rheumatologic diseases under-
going immunobiological treatment. Vaccines made from dead viruses and
bacteriasare indicated in this group of patients. However, vaccines containing
bacterias or live virus such as yellow fever vaccine, are contra indicated be-
cause they have the potential to cause uncontrollable infection. We describe
a case of a patient in use of immmunobiological drug who received yellow
fever vaccine without medical consent, the side effects observed, potencial
risks and management of this patient by Santhe’s staff.
Patricia Avila Fabrini has an in fusional center in Belo
Horizonte, Minas Gerais, Brazil. She has her expertise
in immunobiological drugs and in her center of treat-
ment, she also has a vaccination center for the safety
use of these drugs that acts in the immune systems
of patients.
saudesanthe@hotmail.comBIOGRAPHY